ALGEMENE GENEESKUNDE, Dr. Ch. De Reze SRL
0.5 FTEALGEMENE GENEESKUNDE, Dr. Ch. De Reze reported total assets of 616,002 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026), with 0.5 full-time equivalent.
By total assets for 2025, ALGEMENE GENEESKUNDE, Dr. Ch. De Reze ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +47 % Total assets -3 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ALGEMENE GENEESKUNDE, Dr. Ch. De Reze's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 49,342 € | ||||
| Equity | 450,871 € | ||||
| Cash | 125,731 € | ||||
| EBITDA | 123,420 € | ||||
| Total assets | 616,002 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 04 Aug 2022
ALGEMENE GENEESKUNDE, Dr. Ch. De Reze's financial analysis
- Solvency73.2%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze
1 active director(s) in the register.
ALGEMENE GENEESKUNDE, Dr. Ch. De Reze's shareholders and holdings →ALGEMENE GENEESKUNDE, Dr. Ch. De Reze's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0448.941.635
- VAT number
- BE0448941635
- Peppol
- Registered · 0208:0448941635 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Dec 1992
- Registered office
- 2200 Herentals
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
ALGEMENE GENEESKUNDE, Dr. Ch. De Reze (SRL) has been based in Herentals since 1992, active in: general medical practice activities. For 2025, it reports a net profit of 49,342 € and equity of 450,871 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 73.2%, above the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ALGEMENE GENEESKUNDE, Dr. Ch. De Reze
Companies in the same business, of comparable size and area, outside its group.
- Dr. Thomas Staels General medical practice activities Zandhoven · balance sheet 614,911 €
- DR Denckens Kathleen General medical practice activities Zoersel · balance sheet 619,854 €
- VIBB General medical practice activities Geel · balance sheet 621,457 €
- Dr. Jaak Bussels General medical practice activities Heist-op-den-Berg · balance sheet 606,172 €
- Simon Flies General medical practice activities Antwerp · balance sheet 611,306 €
- Cabinet Medical du Docteur Busellato General medical practice activities Le Roeulx · balance sheet 610,685 €
- Dr. de Cock General medical practice activities Mortsel · balance sheet 609,267 €
- Dokter Camps Kristof Algemene Geneeskunde General medical practice activities Tessenderlo-Ham · balance sheet 624,803 €
Frequently asked questions about ALGEMENE GENEESKUNDE, Dr. Ch. De Reze
What is the revenue of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
ALGEMENE GENEESKUNDE, Dr. Ch. De Reze files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
In Belgium, the VAT number is the company number prefixed with BE: BE0448941635 for ALGEMENE GENEESKUNDE, Dr. Ch. De Reze, if the company is VAT-registered. Its company number (CBE) is 0448.941.635.
Where is the registered office of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
According to the CBE register, the registered office of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze is in 2200 Herentals.
What is the equity of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
At the close of the 2025 financial year, the equity of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze amounts to 450,871 €, a solvency of 73.2% of total assets.
How many people work at ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ALGEMENE GENEESKUNDE, Dr. Ch. De Reze?
The register lists 1 active mandates at ALGEMENE GENEESKUNDE, Dr. Ch. De Reze. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ALGEMENE GENEESKUNDE, Dr. Ch. De Reze within its sector?
By total assets for 2025, ALGEMENE GENEESKUNDE, Dr. Ch. De Reze ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.
The full file of ALGEMENE GENEESKUNDE, Dr. Ch. De Reze
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →